6442
J . Org. Chem. 1998, 63, 6442-6443
hydroxylamine hydrochloride and TsOH in EtOH6 afforded
50% of the oxime ester, which was reduced with BH3‚NMe3
in acidic ethanol7 to give 69% of hydroxylamine 7.
Condensation of hydroxylamine 7 with ketone 8 in EtOH
gave nitrone 5, which was treated with ethyl acrylate in
toluene at reflux for 4 h to give 74% of a 9:1 mixture of
isoxazolidine 4 and the diastereomer. This mixture was
Syn th esis of Desm eth yla m in o F R901483
Barry B. Snider,* Hong Lin, and Bruce M. Foxman
Department of Chemistry, Brandeis University,
Waltham, Massachusetts 02454-9110
Received J uly 6, 1998
FR901483 (1), a novel immunosuppressant, has been
isolated from the fermentation broth of Cladobotrym sp. No.
11231 by a Fujisawa group.1 The structure has been
determined X-ray crystallographically. FR901483 exerts
potent immunosuppressive activity in vitro and significantly
prolongs graft survival time in the rat skin allograft model,
apparently by inhibition of purine nucleotide biosynthesis.
The azatricyclic structure with a phosphate ester is struc-
turally novel and is probably derived biosynthetically from
a tyrosine dimer by oxidative coupling to close the pyrroli-
dine ring and an aldol reaction to form the tricyclic skeleton.
This analysis suggested that 1 could be prepared by an
aldol reaction of keto aldehyde 2. While this should provide
reduced over 10% Pd/C under 45 psi H2 in AcOH for 24 h to
give 91% of a 9:1 mixture of lactam 3 and the diastereomer.
Recrystallization in a mixture of CH2Cl2, hexane, and EtOAc
gave the pure major diastereomer 3. The stereochemistry
was determined to be that needed for elaboration to FR901483
by X-ray crystallographic structure determination.8
The methylamino group was easily introduced by tosyla-
tion of 3 (TsCl, DMAP, Et3N in CH2Cl2, 12 h) to give 99% of
tosylate 9, which was treated with NaN3 in DMF to give
89% of the azide. Hydrogenation of the azide over Pd/C gave
the amine, which was treated with BOC2O to give carbamate
10 quantitatively. Methylation of 10 with NaH and MeI
gave 86% of N-methylcarbamate 11. Because of concerns
about the possible stereochemical complexity of the aldol
reaction of 2, we decided to investigate this step first on
model 13 lacking the protected N-methylamino substituent.
Reaction of tosylate 9 with NaI in acetone at reflux gave
99% of the iodide, which was reduced with SnBu3H and
AIBN in toluene at reflux to give 97% of lactam 12.
Reduction of the ester with LiBH4 in ether/THF afforded the
primary alcohol, which was treated with HCl, AcOH, and
water to cleave the ketal, affording 79% of the keto alcohol
from 12. Oxidation of the primary alcohol with Dess-
Martin reagent provided 82% of the requisite keto aldehyde
13, which can only give four aldol products, rather than the
eight possible from 2. Keto aldehyde 13 has a single chiral
center, so that enolization of the aldehyde will have no effect
in the racemic series.
efficient access to the ring system, there were stereochemical
concerns since the aldol reaction of 2 could give eight
products. Enolization of the ketone can occur at carbons a
or b, addition to the aldehyde can occur to give either the
equatorial or axial alcohol, and enolization of the aldehyde
will convert 2 to a diastereomer that would give four
additional aldol products. Keto aldehyde 2 should be easily
formed from lactam acetal ester 3, which should be readily
available from isoxazolidine 4, which will be constructed by
1,3-dipolar cycloaddition of nitrone 5 with ethyl acrylate.
Although this route to spirocyclic lactams is well-prece-
dented with simple nitrones,2 there are stereochemical
questions in the cycloaddition with 5,3 which will give two
diastereomers. Despite concerns about stereochemical con-
trol in the aldol and cycloaddition steps, the brevity of this
route makes it an attractive approach to FR901483.4
p-Methoxybenzaldehyde and hydantoin were converted to
(p-methoxyphenyl)pyruvic acid (6).5 Reaction of 6 with
We were delighted to find that the aldol reaction9 occurred
readily with acceptable stereocontrol. Cyclization of 13 with
(4) For other approaches to this ring system, see: (a) Quirante, J .;
Escolano, C.; Massot, M.; Bonjoch, J . Tetrahedron 1997, 53, 1391. (b)
Yamazaki, N.; Suzuki, H.; Kibayashi, C. J . Org. Chem. 1997, 62, 8280.
(5) Billek, G. Organic Syntheses; Wiley: New York, 1973; Collect. Vol.
V, p 627.
(6) Ottenheijm, H. C. J .; Plate, R.; Noordik, J . H.; Herscheid, J . D. M. J .
Org. Chem. 1982, 47, 2147.
(7) Plate, R.; Hermkens, P. H. H.; Smits, J . M. M.; Ottenheijm, H. C. J .
J . Org. Chem. 1986, 51, 309.
(1) Sakamoto, K.; Tsujii, E.; Abe, F.; Nakanishi, T.; Yamashita, M.;
Shigematsu, N.; Izumi, S.; Okuhara, M. J . Antibiot. 1996, 49, 37.
(2) (a) Funk, R. L.; Daggett, J . U. Heterocycles 1987, 26, 2175. (b) Blum,
C.; Hutchison, A. US Pat. US005286860A; Chem. Abstr. 1994, 120, 245160b.
(3) For a review of asymmetric 1,3-dipolar cycloadditions, see: Gothelf,
K. V.; J ørgensen, K. A. Chem. Rev. 1998, 98, 863.
(8) X-ray crystallographic data have been deposited at the Cambridge
Crystallographic Data Centre.
(9) For the synthesis of azabicyclo[3.3.1]nonanes or bicyclo[3.3.1]nonanes
by aldol reactions, see: (a) Kinney, W. A.; Crouse, G. D.; Paquette, L. A. J .
Org. Chem. 1983, 48, 4986. (b) Patir, S.; Rosenmund, P.; Go¨tz, P. H.
Heterocycles 1996, 43, 15.
S0022-3263(98)01292-4 CCC: $15.00 © 1998 American Chemical Society
Published on Web 08/26/1998